Director, Risk Management
Mallinckrodt - Hazelwood, MO

This job posting is no longer available on CareerBuilder. Find similar jobs: Director jobs - Mallinckrodt jobs

Are you Covidien? Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit http://www.covidien.com to learn more about our business. Founded as Mallinckrodt in 1867, the $2 billion Covidien pharmaceutical segment is in the process of spinning off into a separate business. This creates exciting opportunities to grow your career within an established organization that is soon to be an independent public company. Currently, the Company expects that the spinoff process will be completed in mid-2013. While we are undergoing the process, the pharmaceuticals business remains a segment of Covidien, and will continue to operate according to the Company's strategic plan, focusing on our customers and patients who rely on our products. Equally important, pharmaceuticals' mission remains the same: To make diagnostics and medicines better and safer for you and your family. Position Summary The purpose of the Director of Risk Management position is to have a broad grasp of the Risk Management function. This person should be a forward thinker, capable of developing and maintaining the organization's Risk Management program, policies and approach to risk management: strategically helping to drive continuous improvement. Primary responsibility will be the management and resolution of claims; working in concert with other Risk Management Department team members and other Company departments, to manage the worldwide corporate property insurance program. Assisting in the development of insurance specifications and placement of appropriate insurance cover to mitigate risk and provide solutions to everyday challenges faced by the group. Principal Accountabilities Responsible for managing the organization's insurance risk as it relates to insurance coverage including, but not limited to, Workers' Compensation, auto (fleet) liability, property liability and product liability on a global basis. Will establish the strategy around risk mitigation, including insurance coverage and other risk mitigation programs (i.e.., annual property replacement valuation analysis, disaster recovery/BCP). Will provide information to and facilitate quarterly Risk reviews with identified stakeholders, resulting in establishing required financial reserves. Responsible for contract negotiation and vendor management. Manage and resolve general liability claims. Manage and resolve property and financial claims. Manage property risks worldwide. Requirements Bachelor's Degree in Business Administration, Accounting or Finance 12+ years of related experience in Risk Management Associate in Risk Management ("ARM") designation preferred Skills/Competencies: Unquestionable integrity, objectivity and independence Demonstrated ability to lead through influence and effectively manage through complex issues and relationships Highly motivated, positive attitude, self directed and assertive Strong negotiating and interpersonal skills Good analytical and problem solving skills
Bachelor's Degree in Business Administration, Accounting or Finance 12+ years of related experience in Risk Management Associate in Risk Management ("ARM") designation preferred

CareerBuilder - 22 months ago - save job - block
Recommended Jobs
Information Assurance Specialist – ISSE and A...
Leidos - St. Louis, MO
Leidos - 30+ days ago

Claims Director, Risk Management
CJ Walsh Group - St. Louis, MO
CJ Walsh Group - 30+ days ago
About this company
24 reviews
In July 2013, Mallinckrodt Pharmaceuticals became an independent, publicly traded, $2.1 billion company. We’re now driven by a new...